First-line gemcitabine and carboplatin in advanced ovarian carcinoma: a phase II study.


OBJECTIVES To evaluate tumour response rate and toxicities of gemcitabine and carboplatin in chemonaive subjects with advanced epithelial ovarian cancer. DESIGN A phase II study. SETTING Gynaecologic oncologic unit. POPULATION Twenty chemonaive International Federation of Gynecology and Obstetrics (FIGO) stage IIIc and stage IV subjects with ovarian… (More)


  • Presentations referencing similar topics